PI3Kδ

Dan Liu1, Bin Yan2, Yiwei Yin3

  • 1Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Ophthalmology, Hunan Key Laboratory of Ophthalmology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

概括

来自黄斑膜患者的玻璃体通过PI3Kδ.驱动上皮层-介质细胞过渡 (EMT). 抑制PI3Kδ (氨基酸3-激酶-三角) 阻断了EMT和纤维化,这表明它是一种治疗膜 (ERM) 的治疗标.